Net-Zero in Pharma: Balancing Molecules, Mandates, and Material Reality
By Shankari Swaminathan | Spectrum “Net-zero by 2040.”“Carbon-neutral operations.” These commitments now populate annual reports, investor decks, and ESG disclosures across the global pharmaceutical…
